<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38450137</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>24</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2296-2565</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in public health</Title><ISOAbbreviation>Front Public Health</ISOAbbreviation></Journal><ArticleTitle>Cohort profile: the British Columbia COVID-19 Cohort (BCC19C)-a dynamic, linked population-based cohort.</ArticleTitle><Pagination><StartPage>1248905</StartPage><MedlinePgn>1248905</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1248905</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fpubh.2024.1248905</ELocationID><Abstract><AbstractText Label="PURPOSE">The British Columbia COVID-19 Cohort (BCC19C) was developed from an innovative, dynamic surveillance platform and is accessed/analyzed through a cloud-based environment. The platform integrates recently developed provincial COVID-19 datasets (refreshed daily) with existing administrative holdings and provincial registries (refreshed weekly/monthly). The platform/cohort were established to inform the COVID-19 response in near "real-time" and to answer more in-depth epidemiologic questions.</AbstractText><AbstractText Label="PARTICIPANTS">The surveillance platform facilitates the creation of large, up-to-date analytic cohorts of people accessing COVID-19 related services and their linked medical histories. The program of work focused on creating/analyzing these cohorts is referred to as the BCC19C. The administrative/registry datasets integrated within the platform are not specific to COVID-19 and allow for selection of "control" individuals who have not accessed COVID-19 services.</AbstractText><AbstractText Label="FINDINGS TO DATE">The platform has vastly broadened the range of COVID-19 analyses possible, and outputs from BCC19C analyses have been used to create dashboards, support routine reporting and contribute to the peer-reviewed literature. Published manuscripts (total of 15 as of July, 2023) have appeared in high-profile publications, generated significant media attention and informed policy and programming. In this paper, we conducted an analysis to identify sociodemographic and health characteristics associated with receiving SARS-CoV-2 laboratory testing, testing positive, and being fully vaccinated. Other published analyses have compared the relative clinical severity of different variants of concern; quantified the high "real-world" effectiveness of vaccines in addition to the higher risk of myocarditis among younger males following a 2nd dose of an mRNA vaccine; developed and validated an algorithm for identifying long-COVID patients in administrative data; identified a higher rate of diabetes and healthcare utilization among people with long-COVID; and measured the impact of the pandemic on mental health, among other analyses.</AbstractText><AbstractText Label="FUTURE PLANS">While the global COVID-19 health emergency has ended, our program of work remains robust. We plan to integrate additional datasets into the surveillance platform to further improve and expand covariate measurement and scope of analyses. Our analyses continue to focus on retrospective studies of various aspects of the COVID-19 pandemic, as well as prospective assessment of post-acute COVID-19 conditions and other impacts of the pandemic.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Wilton, Abdulmenan, Chong, Becerra, Najmul Hussain, Harrigan, Vel&#xe1;squez Garc&#xed;a, Naveed, Sbihi, Smolina, Taylor, Adhikari, Zandy, Setayeshgar, Li, Abdia, Binka, Rasali, Rose, Coss, Flatt, Mussavi Rizi and Janjua.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wilton</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>BC Center for Disease Control, Provincial Health Services Authority, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdulmenan</LastName><ForeName>Jalud</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Data Analytics, Reporting, and Evaluation, Provincial Health Services Authority, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chong</LastName><ForeName>Mei</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>BC Center for Disease Control, Provincial Health Services Authority, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Trauma Services British Columbia, Provincial Health Services Authority, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Becerra</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>BC Center for Disease Control, Provincial Health Services Authority, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vancouver Coastal Health, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Najmul Hussain</LastName><ForeName>Mehazabeen</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Data Analytics, Reporting, and Evaluation, Provincial Health Services Authority, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harrigan</LastName><ForeName>Sean P</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>BC Center for Disease Control, Provincial Health Services Authority, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vel&#xe1;squez Garc&#xed;a</LastName><ForeName>H&#xe9;ctor Alexander</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>BC Center for Disease Control, Provincial Health Services Authority, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naveed</LastName><ForeName>Zaeema</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>BC Center for Disease Control, Provincial Health Services Authority, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sbihi</LastName><ForeName>Hind</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>BC Center for Disease Control, Provincial Health Services Authority, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smolina</LastName><ForeName>Kate</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>BC Center for Disease Control, Provincial Health Services Authority, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>Marsha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>BC Center for Disease Control, Provincial Health Services Authority, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adhikari</LastName><ForeName>Binay</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>BC Center for Disease Control, Provincial Health Services Authority, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zandy</LastName><ForeName>Moe</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>BC Center for Disease Control, Provincial Health Services Authority, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vancouver Coastal Health, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Setayeshgar</LastName><ForeName>Solmaz</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>BC Center for Disease Control, Provincial Health Services Authority, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>BC Center for Disease Control, Provincial Health Services Authority, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdia</LastName><ForeName>Younathan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>BC Center for Disease Control, Provincial Health Services Authority, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Binka</LastName><ForeName>Mawuena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>BC Center for Disease Control, Provincial Health Services Authority, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasali</LastName><ForeName>Drona</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>BC Center for Disease Control, Provincial Health Services Authority, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rose</LastName><ForeName>Caren</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>BC Center for Disease Control, Provincial Health Services Authority, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coss</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Data Analytics, Reporting, and Evaluation, Provincial Health Services Authority, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flatt</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Provincial Health Services Authority, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mussavi Rizi</LastName><ForeName>Seyed Ali</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Data Analytics, Reporting, and Evaluation, Provincial Health Services Authority, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Janjua</LastName><ForeName>Naveed Zafar</ForeName><Initials>NZ</Initials><AffiliationInfo><Affiliation>BC Center for Disease Control, Provincial Health Services Authority, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Health Evaluation and Outcome Sciences, St. Paul's Hospital, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Public Health</MedlineTA><NlmUniqueID>101616579</NlmUniqueID><ISSNLinking>2296-2565</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001955" MajorTopicYN="N" Type="Geographic">British Columbia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">administrative data</Keyword><Keyword MajorTopicYN="N">cohort profile</Keyword><Keyword MajorTopicYN="N">linked data</Keyword><Keyword MajorTopicYN="N">population-based data</Keyword></KeywordList><CoiStatement>NJ reported receiving personal fees from Gilead and AbbVie outside the submitted work. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>7</Day><Hour>4</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38450137</ArticleId><ArticleId IdType="pmc">PMC10914982</ArticleId><ArticleId IdType="doi">10.3389/fpubh.2024.1248905</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>BC Centre for Disease Control . British Columbia COVID-19 Dashboard. Available online at: https://experience.arcgis.com/experience/a6f23959a8b14bfa989e3cda29297ded (accessed June 26, 2023).</Citation></Reference><Reference><Citation>BC Centre for Disease Control . COVID-19 Vaccination Coverage. Available online at: http://www.bccdc.ca/health-professionals/data-reports/covid-19-vaccination-coverage (accessed June 26, 2023).</Citation></Reference><Reference><Citation>Wilton J, Abdulmenan J, Chong M, et al. . A large linked data platform to inform the COVID-19 response in British Columbia: The BC COVID-19 Cohort. Int J Popul Data Sci. (2022) 7. 10.23889/ijpds.v7i3.2095</Citation><ArticleIdList><ArticleId IdType="doi">10.23889/ijpds.v7i3.2095</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulholland RH, Vasileiou E, Simpson CR, Robertson C, Ritchie LD, Agrawal U, et al. . Cohort profile: early pandemic evaluation and enhanced surveillance of COVID-19 (EAVE II) database. Int J Epidemiol. (2021) 50:1064&#x2013;74. 10.1093/ije/dyab028</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyab028</ArticleId><ArticleId IdType="pmc">PMC8195245</ArticleId><ArticleId IdType="pubmed">34089614</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizi SAM, Roudsari A. Development of a public health reporting data warehouse: lessons learned. Stud Health Technol Inform. (2013) 192:861&#x2013;5. 10.3233/978-1-61499-289-9-861</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/978-1-61499-289-9-861</ArticleId><ArticleId IdType="pubmed">23920680</ArticleId></ArticleIdList></Reference><Reference><Citation>BC Centre for Disease Control . Respiratory Surveillance: Community Visits For Respiratory Illness. Available online at: https://bccdc.shinyapps.io/respiratory_community_visits/ (accessed June 26, 2023).</Citation></Reference><Reference><Citation>Vel&#xe1;squez Garc&#xed;a HA, Wilton J, Smolina K, Chong M, Rasali D, Otterstatter M, et al. . Mental health and substance use associated with hospitalization among people with COVID-19: a population-based cohort study. Viruses. (2021) 13:2196. 10.3390/v13112196</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13112196</ArticleId><ArticleId IdType="pmc">PMC8624346</ArticleId><ArticleId IdType="pubmed">34835002</ArticleId></ArticleIdList></Reference><Reference><Citation>Vel&#xe1;squez Garc&#xed;a HA, Adu PA, Harrigan S, Wilton J, Rasali D, Binka M, et al. . Risk factors for COVID-19 hospitalization after COVID-19 vaccination: a population-based cohort study in Canada. Int J Infect Dis. (2023) 127:116&#x2013;23. 10.1016/j.ijid.2022.12.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.12.001</ArticleId><ArticleId IdType="pmc">PMC9731811</ArticleId><ArticleId IdType="pubmed">36503044</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrigan SP, Wilton J, Chong M, Abdia Y, Garcia HV, Rose C, et al. . Clinical severity of severe acute respiratory syndrome coronavirus 2 omicron variant relative to delta in British Columbia, Canada: a retrospective analysis of whole-genome sequenced cases. Clin Infect Dis. (2023) 76:e18&#x2013;25. 10.1093/cid/ciac705</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac705</ArticleId><ArticleId IdType="pmc">PMC9452171</ArticleId><ArticleId IdType="pubmed">36041009</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell SL, Klaver BRA, Harrigan SP, Kamelian K, Tyson J, Hoang L, et al. . Clinical severity of Omicron subvariants BA.1, BA2, and BA5 in a population-based cohort study in British Columbia, Canada. J Med Virol. (2023) 95:e28423. 10.1002/jmv.28423</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28423</ArticleId><ArticleId IdType="pubmed">36546412</ArticleId></ArticleIdList></Reference><Reference><Citation>JMIR Preprints . Clinical Severity of SARS-CoV-2 Variants of Concern in British Columbia, Canada: A Retrospective Population-Based Comparative Analysis. JMIR Preprints. Available online at: https://preprints.jmir.org/preprint/45513 (accessed March 31, 2023).</Citation></Reference><Reference><Citation>Setayeshgar S, Wilton J, Sbihi H, Zandy M, Janjua N, Choi A, et al. . Comparison of influenza and COVID-19 hospitalisations in British Columbia, Canada: a population-based study. BMJ Open Resp Res. (2023) 10:e001567. 10.1136/bmjresp-2022-001567</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjresp-2022-001567</ArticleId><ArticleId IdType="pmc">PMC9895913</ArticleId><ArticleId IdType="pubmed">36731922</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Vaccine Data Network . Background Rates Dashboards. Available online at: https://www.globalvaccinedatanetwork.org/Data-Dashboards/Background-Rates-Dashboards/GVDN%20AESI%20Background%20rates%202015%E2%80%932020 (accessed June 26, 2023).</Citation></Reference><Reference><Citation>Naveed Z, Li J, Spencer M, Wilton J, Naus M, Garc&#xed;a HAV, et al. . Observed versus expected rates of myocarditis after SARS-CoV-2 vaccination: a population-based cohort study. CMAJ. (2022) 194:E1529&#x2013;36. 10.1503/cmaj.220676</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.220676</ArticleId><ArticleId IdType="pmc">PMC9828950</ArticleId><ArticleId IdType="pubmed">36410749</ArticleId></ArticleIdList></Reference><Reference><Citation>Naveed Z, Li J, Wilton J, Spencer M, Naus M, Vel&#xe1;squez Garc&#xed;a HA, et al. . Comparative risk of myocarditis/pericarditis following second doses of BNT162b2 and mRNA-1273 coronavirus vaccines. J Am Coll Cardiol. (2022) 80:1900&#x2013;8. 10.1016/j.jacc.2022.08.799</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2022.08.799</ArticleId><ArticleId IdType="pmc">PMC9639791</ArticleId><ArticleId IdType="pubmed">36357091</ArticleId></ArticleIdList></Reference><Reference><Citation>Naveed Z, Li J, Naus M, Garc&#xed;a HAV, Wilton J, Janjua NZ. A population-based assessment of myocarditis following mRNA COVID-19 booster vaccination among adult recipients. Int J Infect Dis. (2023) 131:75&#x2013;8. 10.1016/j.ijid.2023.03.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2023.03.027</ArticleId><ArticleId IdType="pmc">PMC10037911</ArticleId><ArticleId IdType="pubmed">36967038</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasreen S, Febriani Y, Garc&#xed;a HAV, Zhang G, Tadrous M, Buchan SA, et al. . Effectiveness of Coronavirus Disease 2019 vaccines against hospitalization and death in Canada: a multiprovincial, test-negative design study. Clin Infect Dis. (2023) 76:640&#x2013;8. 10.1093/cid/ciac634</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac634</ArticleId><ArticleId IdType="pmc">PMC9384799</ArticleId><ArticleId IdType="pubmed">35974428</ArticleId></ArticleIdList></Reference><Reference><Citation>Fowokan A, Samji H, Puyat JH, Janjua NZ, Wilton J, Wong J, et al. . Effectiveness of COVID-19 vaccines in people living with HIV in British Columbia and comparisons with a matched HIV-negative cohort: a test-negative design. Int J Infect Dis. (2023) 127:162&#x2013;70. 10.1016/j.ijid.2022.11.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.11.035</ArticleId><ArticleId IdType="pmc">PMC9711901</ArticleId><ArticleId IdType="pubmed">36462571</ArticleId></ArticleIdList></Reference><Reference><Citation>Zandy M, El Kurdi S, Samji H, McKee G, Gustafson R, Smolina K. Mental health-related healthcare service utilisation and psychotropic drug dispensation trends in British Columbia during COVID-19 pandemic: a population-based study. Gen Psych. (2023) 36:e100941. 10.1136/gpsych-2022-100941</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gpsych-2022-100941</ArticleId><ArticleId IdType="pmc">PMC9971830</ArticleId><ArticleId IdType="pubmed">36875149</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao J, Irvine M, Klaver B, Zandy M, Dheri AK, Grafstein E, et al. . Changes in emergency department use in British Columbia, Canada during the first three years of COVID-19 pandemic. CMAJ. (2023) 195:E1141&#x2013;50. 10.1503/cmaj.221516</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.221516</ArticleId><ArticleId IdType="pmc">PMC10480001</ArticleId><ArticleId IdType="pubmed">37669788</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia Y, Ma H, Moloney G, Garc&#xed;a HAV, Sirski M, Janjua NZ, et al. . Geographic concentration of SARS-CoV-2 cases by social determinants of health in metropolitan areas in Canada: a cross-sectional study. CMAJ. (2022) 194:E195&#x2013;204. 10.1503/cmaj.211249</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.211249</ArticleId><ArticleId IdType="pmc">PMC8900797</ArticleId><ArticleId IdType="pubmed">35165131</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasali D, Adhikari B, Vel&#xe1;squez-Garc&#xed;a H, et al. . Syndemic association of COVID-19 diagnosis with diabetes across socio-demographic disparities in British Columbia (BC) population, 2020&#x2013;2021. Ann Epidemiol. (2022) 75:81&#x2013;2. 10.1016/j.annepidem.2022.08.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annepidem.2022.08.030</ArticleId></ArticleIdList></Reference><Reference><Citation>Binka M, Klaver B, Cua G, Wong AW, Fibke C, Garc&#xed;a HAV, et al. . An elastic net regression model for identifying long COVID patients using health administrative data: a population-based study. Open Forum Infect Dis. (2022) 9:ofac640. 10.1093/ofid/ofac640</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac640</ArticleId><ArticleId IdType="pmc">PMC9780702</ArticleId><ArticleId IdType="pubmed">36570972</ArticleId></ArticleIdList></Reference><Reference><Citation>Binka M, Klaver B, Cua G, Sander B, Sbihi H, Janjua NZ. Healthcare utilization remains elevated among people living with post-COVID-19 condition more than one year after acute COVID-19 illness. In: The Professional Society for Health Economics and Outcomes Research (ISPOR). Boston, MA (2023).</Citation></Reference><Reference><Citation>Naveed Z, Vel&#xe1;squez Garc&#xed;a HA, Wong S, Wilton J, McKee G, Mahmood B, et al. . Association of COVID-19 infection with incident diabetes. JAMA Netw Open. (2023) 6:e238866. 10.1001/jamanetworkopen.2023.8866</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.8866</ArticleId><ArticleId IdType="pmc">PMC10114057</ArticleId><ArticleId IdType="pubmed">37071420</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernasconi A, Ceri S. Interoperability of COVID-19 clinical phenotype data with host and viral genetics data. BioMed. (2022) 2:69&#x2013;81. 10.3390/biomed2010007</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomed2010007</ArticleId></ArticleIdList></Reference><Reference><Citation>Pampalon R, Gamache P, Hamel D. A deprivation index for health planning in Canada. Chronic Dis Can. (2009) 29:178&#x2013;91. 10.24095/hpcdp.29.4.05</Citation><ArticleIdList><ArticleId IdType="doi">10.24095/hpcdp.29.4.05</ArticleId><ArticleId IdType="pubmed">19804682</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>